Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Novo Nordisk's European stock rose 8.6% after Hims & Hers Health canceled its generic Wegovy weight loss pill project

Novo Nordisk's European stock rose 8.6% after Hims & Hers Health canceled its generic Wegovy weight loss pill project

Wallstreetcn

Feb 9, 2026 at 02:07 AM

Novo Nordisk's European stock rose 8.6% after Hims canceled its generic Wegovy weight loss pill project

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Novo Nordisk AS

USNVO

+3.71%

NUODE

SH600110

+3.64%

Hims & Hers Health

USHIMS

+2.16%

LongbridgeAI